Memphasys Limited (MEM.AX)

AUD 0.01

(0.0%)

Gross Profit Summary of Memphasys Limited

  • Memphasys Limited's latest annual gross profit in 2024 was 1606.00 AUD , up 93.28% from previous year.
  • Memphasys Limited's latest quarterly gross profit in 2024 FY was -1.62 Million AUD , down -97.02% from previous quarter.
  • Memphasys Limited reported a annual gross profit of -824.86 Thousand AUD in annual gross profit 2023, up 10.59% from previous year.
  • Memphasys Limited reported a annual gross profit of -922.59 Thousand AUD in annual gross profit 2022, down -1821.92% from previous year.
  • Memphasys Limited reported a quarterly gross profit of -1.62 Million AUD for 2024 FY, down -97.02% from previous quarter.
  • Memphasys Limited reported a quarterly gross profit of -591.58 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Memphasys Limited (2024 - 2008)

Historical Annual Gross Profit of Memphasys Limited (2024 - 2008)

Year Gross Profit Gross Profit Growth
2024 1606.00 AUD 93.28%
2023 -824.86 Thousand AUD 10.59%
2022 -922.59 Thousand AUD -1821.92%
2021 -48 Thousand AUD 75.54%
2020 -196.23 Thousand AUD -2099.9%
2019 -8920.00 AUD 57.43%
2018 -20.95 Thousand AUD -1.24%
2017 -20.69 Thousand AUD -146.5%
2016 44.51 Thousand AUD 103.2%
2015 21.9 Thousand AUD -85.44%
2014 150.46 Thousand AUD 170.02%
2013 55.72 Thousand AUD -96.53%
2012 1.6 Million AUD 43.92%
2011 1.11 Million AUD -74.95%
2010 4.45 Million AUD 325.0%
2009 1.04 Million AUD 719.09%
2008 127.9 Thousand AUD 0.0%

Peer Gross Profit Comparison of Memphasys Limited

Name Gross Profit Gross Profit Difference
EZZ Life Science Holdings Limited 50.94 Million AUD 99.997%
Anatara Lifesciences Ltd -748.91 Thousand AUD 100.214%
Zelira Therapeutics Limited 10.28 Thousand AUD 84.384%
Biome Australia Limited 7.66 Million AUD 99.979%
Patrys Limited 1.39 Million AUD 99.885%
Orthocell Limited 3.68 Million AUD 99.956%
Imugene Limited -5.83 Million AUD 100.028%
Noxopharm Limited -534.81 Thousand AUD 100.3%
PYC Therapeutics Limited 22.05 Million AUD 99.993%
Chimeric Therapeutics Limited 7.45 Million AUD 99.978%
Prescient Therapeutics Limited 3.71 Million AUD 99.957%
Proteomics International Laboratories Limited -1.12 Million AUD 100.143%
Cynata Therapeutics Limited 2.31 Million AUD 99.931%
CSL Limited 15.28 Billion AUD 100.0%
Arovella Therapeutics Limited -25.97 Thousand AUD 106.182%
Bio-Gene Technology Limited -301.44 Thousand AUD 100.533%
Clinuvel Pharmaceuticals Limited 78.09 Million AUD 99.998%
Starpharma Holdings Limited 7.65 Million AUD 99.979%
Nanollose Limited -348.95 Thousand AUD 100.46%
Invex Therapeutics Ltd 1.21 Million AUD 99.868%
NeuroScientific Biopharmaceuticals Limited -91.33 Thousand AUD 101.758%
Amplia Therapeutics Limited 4.01 Million AUD 99.96%
Botanix Pharmaceuticals Limited -6.55 Million AUD 100.025%
Island Pharmaceuticals Limited 1.25 Million AUD 99.872%
Race Oncology Limited 1.38 Million AUD 99.884%
Nyrada Inc. -5164.07 AUD 131.1%
Telix Pharmaceuticals Limited 308.5 Million AUD 99.999%
Dimerix Limited 583.47 Thousand AUD 99.725%
PharmAust Limited -1641.00 AUD 197.867%
Immutep Limited 1.44 Million AUD 99.889%
Clarity Pharmaceuticals Ltd 11.5 Million AUD 99.986%
Alterity Therapeutics Limited 3.8 Million AUD 99.958%
BTC Health Limited 16.36 Thousand AUD 90.183%
Acrux Limited -1.28 Million AUD 100.125%
Neuren Pharmaceuticals Limited 205.17 Million AUD 99.999%
Biotron Limited -40.49 Thousand AUD 103.966%
Tissue Repair Ltd 150.51 Thousand AUD 98.933%
AdAlta Limited 1.5 Million AUD 99.893%
Radiopharm Theranostics Limited -21.3 Million AUD 100.008%
Hexima Limited - AUD -Infinity%
AnteoTech Limited 460.39 Thousand AUD 99.651%
Paradigm Biopharmaceuticals Limited 56.81 Thousand AUD 97.173%
Recce Pharmaceuticals Ltd -366.76 Thousand AUD 100.438%
Avecho Biotechnology Limited -43.79 Thousand AUD 103.667%
Actinogen Medical Limited 9.93 Million AUD 99.984%
Immuron Limited 3.33 Million AUD 99.952%
Argenica Therapeutics Limited 2.59 Million AUD 99.938%